REGN
REGN
NASDAQ · Biotechnology

Regeneron Pharmaceuticals

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks
$784.36
+12.25 (+1.59%)
As of Aug 8, 9:33 PM ET ·
Analyst Consensus
Buy
37
Analysts
Very High
Coverage
Buy 26 70%
Hold 11 30%
Sell 0 0%
Price Target
Analyst Price Target -90.2% upside
Low Target $61.79
Average Target $76.80
High Target $111.17
Current Price $784.36
Current
$784.36
Target
$76.80
$61.79 $76.80 avg $111.17
Scenario Analysis
Bear Case
$61.79
-92.1%
Low target
Base Case
$76.80
-90.2%
Avg target
Bull Case
$111.17
+-85.8%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$821.11
-4.5% from high
52-Week Low
$541.00
+45.0% from low
50-Day SMA
$763.91
+2.7% vs SMA
200-Day SMA
$631.14
+24.3% vs SMA
RSI (14)
59.8
Neutral
Target vs 52W High
$76.80
-90.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.0%